IL17A and prostate carcinoma: The primary signaling pathways encompassed the p53 signaling pathway, IL-17 signaling pathway, Th17 cell differentiation, the AGE-RAGE signaling pathway in diabetic complications, the NF-κB signaling pathway, prostate cancer, and Hepatitis C.